Universal coverage of health services: tailoring its implementation.

PubWeight™: 2.30‹?› | Rank: Top 2%

🔗 View Article (PMC 2649543)

Published in Bull World Health Organ on November 01, 2008

Authors

Guy Carrin1, Inke Mathauer, Ke Xu, David B Evans

Author Affiliations

1: Department of Health Systems Financing, Health Systems and Services, World Health Organization, Geneva, Switzerland. carring@who.int

Articles citing this

Health systems financing and the path to universal coverage. Bull World Health Organ (2010) 4.67

Achieving universal health coverage through voluntary insurance: what can we learn from the experience of Lao PDR? BMC Health Serv Res (2013) 1.18

Catastrophic household expenditure on health in Nepal: a cross-sectional survey. Bull World Health Organ (2014) 1.09

The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire. PLoS One (2010) 1.04

Financing universal coverage in Malaysia: a case study. BMC Public Health (2012) 1.02

Is RSBY India's platform to implementing universal hospital insurance? Indian J Med Res (2012) 0.99

The case of pharmacist prescribing policy in Israel. Isr J Health Policy Res (2015) 0.92

Health insurance benefit design and healthcare utilization in northern rural China. PLoS One (2012) 0.90

Assessing catastrophic and impoverishing effects of health care payments in Uganda. BMC Health Serv Res (2015) 0.89

Assessing responsiveness of health care services within a health insurance scheme in Nigeria: users' perspectives. BMC Health Serv Res (2013) 0.85

Health benefits of reduced patient cost sharing in Japan. Bull World Health Organ (2012) 0.84

Medicalization of global health 4: The universal health coverage campaign and the medicalization of global health. Glob Health Action (2014) 0.83

Inequity in level of healthcare utilization before and after universal health coverage reforms in China: evidence from household surveys in Sichuan Province. Int J Equity Health (2016) 0.79

Inputs for universal health coverage: a methodological contribution to finding proxy indicators for financial hardship due to health expenditure. BMC Health Serv Res (2014) 0.79

Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation (2016) 0.78

Caregiver supportive policies to improve child outcomes in the wake of the HIV/AIDS epidemic: an analysis of the gap between what is needed and what is available in 25 high prevalence countries. AIDS Care (2016) 0.77

The administrative costs of community-based health insurance: a case study of the community health fund in Tanzania. Health Policy Plan (2013) 0.77

Access and barriers to immunization in West Bengal, India: quality matters. J Health Popul Nutr (2013) 0.76

"I go I die, I stay I die, better to stay and die in my house": understanding the barriers to accessing health care in Timor-Leste. BMC Health Serv Res (2016) 0.75

The importance of Leadership towards universal health coverage in Low Income Countries. Malawi Med J (2015) 0.75

Fail to prepare and you can prepare to fail: the experience of financing path changes in teaching hospitals in Iran. BMC Health Serv Res (2016) 0.75

Performance evaluation of a health insurance in Nigeria using optimal resource use: health care providers perspectives. BMC Health Serv Res (2014) 0.75

Achieving universal health coverage through community empowerment: a proposition for bangladesh. Indian J Community Med (2014) 0.75

Consumers' perspectives on national health insurance in South Africa: using a mobile health approach. JMIR Mhealth Uhealth (2014) 0.75

Access to health care: the role of a community based health insurance in Kenya. Pan Afr Med J (2012) 0.75

A quantitative study on factors influencing enrolment of dairy farmers in a community health insurance scheme. BMC Health Serv Res (2016) 0.75

Health for all: a pathway to economic growth in the Association of South-East Asian Nations. Bull World Health Organ (2014) 0.75

Articles by these authors

Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88

Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07

Protecting households from catastrophic health spending. Health Aff (Millwood) (2007) 8.44

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27

Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet (2003) 5.17

Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet (2012) 4.98

The health worker shortage in Africa: are enough physicians and nurses being trained? Bull World Health Organ (2009) 4.78

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72

Health systems financing and the path to universal coverage. Bull World Health Organ (2010) 4.67

Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ (2013) 4.17

A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis (2011) 3.91

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet (2013) 3.74

Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc (2003) 3.65

WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ (2003) 3.42

Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Organ (2008) 3.33

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet (2004) 3.14

Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13

To retain or remove user fees?: reflections on the current debate in low- and middle-income countries. Appl Health Econ Health Policy (2006) 3.06

Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ (2005) 3.05

Understanding the impact of eliminating user fees: utilization and catastrophic health expenditures in Uganda. Soc Sci Med (2005) 3.03

Cost effectiveness analysis of strategies for child health in developing countries. BMJ (2005) 2.71

Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65

Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ (2002) 2.56

A 160-kilobit molecular electronic memory patterned at 10(11) bits per square centimetre. Nature (2007) 2.48

The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst (2013) 2.20

Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain (2004) 2.17

Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol (2006) 1.98

Assessing the reliability of household expenditure data: results of the World Health Survey. Health Policy (2009) 1.91

Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care (2003) 1.90

Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80

Universal health coverage and universal access. Bull World Health Organ (2013) 1.76

New caged coumarin fluorophores with extraordinary uncaging cross sections suitable for biological imaging applications. J Am Chem Soc (2004) 1.74

BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology (2005) 1.74

Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol (2011) 1.72

Does the Integrated Management of Childhood Illness cost more than routine care? Results from the United Republic of Tanzania. Bull World Health Organ (2005) 1.68

Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials. JACC Cardiovasc Interv (2011) 1.66

Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet (2003) 1.64

Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation (2013) 1.62

Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61

Financial burden of household out-of pocket health expenditure in Viet Nam: findings from the National Living Standard Survey 2002-2010. Soc Sci Med (2012) 1.59

Generalised cost-effectiveness analysis: an aid to decision making in health. Appl Health Econ Health Policy (2002) 1.58

Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J (2012) 1.57

Mutual health insurance in Rwanda: evidence on access to care and financial risk protection. Health Policy (2010) 1.57

Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis. J Endovasc Ther (2011) 1.55

Concern Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine. PLoS One (2010) 1.51

Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol (2012) 1.51

Critical role of PIP5KI{gamma}87 in InsP3-mediated Ca(2+) signaling. J Cell Biol (2004) 1.51

Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv (2012) 1.50

Unraveling the origin of exponential law in intra-urban human mobility. Sci Rep (2013) 1.49

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta (2012) 1.48

Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging (2012) 1.48

Measuring the equity of inpatient utilization in Chinese rural areas. BMC Health Serv Res (2011) 1.48

Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study. Coron Artery Dis (2014) 1.47

Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study. Ann Intern Med (2016) 1.46

SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter Cardiovasc Interv (2014) 1.45

Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial. Catheter Cardiovasc Interv (2014) 1.44

Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One (2012) 1.44

ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J (2006) 1.43

Identification of novel factors involved in or regulating initiation of DNA replication by a genome-wide phenotypic screen in Saccharomyces cerevisiae. Cell Cycle (2010) 1.43

Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). Am J Cardiol (2013) 1.42

Potential of diffusion tensor MR imaging in the assessment of cognitive impairments in children with periventricular leukomalacia born preterm. Eur J Radiol (2012) 1.41

The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial. Heart (2013) 1.41

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry (2006) 1.41

Effects of pH, salt, and macromolecular crowding on the stability of FK506-binding protein: an integrated experimental and theoretical study. J Mol Biol (2005) 1.40

Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial. Coron Artery Dis (2015) 1.39

Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care (2002) 1.37

MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol (2012) 1.36

Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31

Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol (2010) 1.30

PEDV ORF3 encodes an ion channel protein and regulates virus production. FEBS Lett (2012) 1.29

LATERAL ORGAN BOUNDARIES DOMAIN transcription factors direct callus formation in Arabidopsis regeneration. Cell Res (2012) 1.27

Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes. Cost Eff Resour Alloc (2006) 1.27

ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem (2006) 1.27

Weak ties: subtle role of information diffusion in online social networks. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 1.26

The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J Gen Virol (2014) 1.26

miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol (2012) 1.26

Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging (2012) 1.24

Effects of different correlation metrics and preprocessing factors on small-world brain functional networks: a resting-state functional MRI study. PLoS One (2012) 1.24

Determinants of variation in the cost of inpatient stays versus outpatient visits in hospitals: a multi-country analysis. Soc Sci Med (2006) 1.23

Designing health financing policy towards universal coverage. Bull World Health Organ (2007) 1.23

Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol (2011) 1.23

A dual-targeting anticancer approach: soil and seed principle. Radiology (2011) 1.21

Capacity constraints to the adoption of new interventions: consultation time and the Integrated Management of Childhood Illness in Brazil. Health Policy Plan (2005) 1.21

Health financing reform in Kenya - assessing the social health insurance proposal. S Afr Med J (2007) 1.20

Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry (2007) 1.20

Nonadditive effects of mixed crowding on protein stability. Proteins (2009) 1.19

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood (2007) 1.19

Assessment of Mandarin-speaking pediatric cochlear implant recipients with the Mandarin Early Speech Perception (MESP) test. Int J Pediatr Otorhinolaryngol (2010) 1.18

Effect of macromolecular crowding on protein binding stability: modest stabilization and significant biological consequences. Biophys J (2009) 1.17

Study raises questions about measurement of 'additionality,'or maintaining domestic health spending amid foreign donations. Health Aff (Millwood) (2012) 1.15

Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging (2012) 1.14

Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis (2013) 1.13

Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol (2009) 1.12

Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology (2012) 1.12

BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci (2008) 1.12

Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin (2009) 1.12

Expression analysis suggests potential roles of microRNAs for phosphate and arbuscular mycorrhizal signaling in Solanum lycopersicum. Physiol Plant (2009) 1.10

The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity. J Biol Chem (2007) 1.09